Group One Trading’s Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda) CYTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-14
| Closed | -$9 | – | 3660 |
|
|
2024
Q3 | $9 | Hold |
14
| – | – | ﹤0.01% | 1668 |
|
|
2024
Q2 | $16 | Hold |
14
| – | – | ﹤0.01% | 1690 |
|
|
2024
Q1 | $29 | Hold |
14
| – | – | ﹤0.01% | 1692 |
|
|
2023
Q4 | $49 | Sell |
14
-1
| -7% | -$4 | ﹤0.01% | 1801 |
|
|
2023
Q3 | $72 | Hold |
15
| – | – | ﹤0.01% | 1826 |
|
|
2023
Q2 | $191 | Buy |
+15
| New | +$191 | ﹤0.01% | 1681 |
|
|
2023
Q1 | – | Sell |
-37
| Closed | -$3.63K | – | 3473 |
|
|
2022
Q4 | $3.63K | Sell |
37
-125
| -77% | -$12.3K | ﹤0.01% | 1601 |
|
|
2022
Q3 | $19K | Sell |
162
-40
| -20% | -$4.69K | ﹤0.01% | 1454 |
|
|
2022
Q2 | $39K | Buy |
202
+70
| +53% | +$13.5K | ﹤0.01% | 1341 |
|
|
2022
Q1 | $58K | Buy |
132
+3
| +2% | +$1.32K | ﹤0.01% | 1393 |
|
|
2021
Q4 | $94K | Buy |
129
+125
| +3,125% | +$91.1K | ﹤0.01% | 1410 |
|
|
2021
Q3 | $3K | Sell |
4
-46
| -92% | -$34.5K | ﹤0.01% | 1965 |
|
|
2021
Q2 | $71K | Buy |
50
+48
| +2,400% | +$68.2K | ﹤0.01% | 1431 |
|
|
2021
Q1 | $3K | Buy |
+2
| New | +$3K | ﹤0.01% | 1739 |
|
|
2017
Q1 | – | Hold |
0
| – | -$4K | – | 1948 |
|
|
2016
Q4 | – | Hold |
0
| – | -$3K | – | 1157 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 1108 |
|